Skip to content

    Recently Viewed



      Johnson & Johnson debuts a groundbreaking R&D facility in the San Francisco Bay Area

      Take a look inside the new cutting-edge hub for medical innovation where company scientists and other researchers will collaborate to help find solutions for some of the world’s toughest health challenges.

      Share Article
      share to

      The new research site, located near the Birthplace of Biotechnology, will be home to scientists focused on finding new solutions for everything from infectious diseases to retinal diseases, using such cutting-edge technologies as gene and RNA therapies and advanced data science.

      And thanks to its Bay Area address, the new site will also enable Silicon Valley healthcare entrepreneurs and other researchers to collaborate with company scientists to help advance the next great healthcare breakthroughs.

      Watch this drone video for an inside look at the new healthcare innovation hub.

      Check out more innovation in action

      Learn how Johnson & Johnson is working to find solutions for some of the world’s toughest health challenges.

      More from Johnson & Johnson

      Two cardiac electrophysiologists performing a cardiac ablation procedure to treat AFib

      What is cardiac ablation?

      For American Heart Month, learn how Johnson & Johnson is innovating to help treat the millions of people who are living with atrial fibrillation and other conditions that cause an irregular heartbeat.
      Latest news
       Biomedical scientist Robert Langer headshot

      Biomedical scientist Robert Langer receives the 2023 Dr. Paul Janssen Award for Biomedical Research

      Each year, Johnson & Johnson honors a scientist currently working in academia, industry or a scientific institute who has made a significant contribution toward the improvement of public health.
      Health & wellness
       Blue latex gloved hand pointing at a brain MRI scan to pinpoint brain circuits associated with depression symptoms

      Is this the end of one-size-fits-all treatments for depression?

      Johnson & Johnson is working to bring personalized psychiatry to the 7 in 10 people with depression whose treatments aren’t getting the job done.
      You are now leaving The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.